Hyaluronic Acid Conjugates of Vorinostat and Bexarotene for Treatment of Cutaneous Malignancies

Abstract

Skin cancer is the most common class of malignancies in humans with increasing incidence worldwide. Although surgery remains the most common treatment approach, relapses after surgery necessitate other treatment options. There is an increasing clinical demand for topical treatments for skin cancer that can improve the drug's cutaneous localization while limiting systemic absorption. In this study, hyaluronic acid (HA) conjugates are successfully synthesized by attaching a third-generation retinoid (bexarotene) and a histone deacetylase inhibitor (vorinostat) to HA via ester bonds. The conjugates are characterized to ensure identity and quantify total drug loading. HA-BEX and HA-VOR exhibit a synergistic anticancer effect against human squamous cell carcinoma (A431) and human cutaneous T cell lymphoma cell lines (HUT 78) at specific ratios with minimal adverse effect on primary human keratinocytes and fibroblasts. Confocal microscopy demonstrates localization of the conjugates inside the cancer cells. Ex vivo skin permeation studies on human skin explants confirm their ability to penetrate the stratum corneum and reach the deep dermis. Biodistribution studies in the skin reveal the presence of both drugs in the epidermis and dermis in amounts sufficient to exert inhibitory effect on cancer cells. HA-bexarotene-vorinostat conjugates offer an excellent therapeutic option to treat skin cancers.

Methotrexate-Lactoferrin Targeted Exemestane Cubosomes for Synergistic Breast Cancer Therapy

“…HCl and potassium salt of Oxyma forming the corresponding active ester ( Cherkupally et al, 2013 ; Jad et al, 2015 ), which was allowed to react with the free amino groups of Lf to create an amide bond ( Scheme 1 ). MTX–Lf conjugate could minimize the side effects, augmenting MTX accumulation within cancer cells and thus maximize its anti-tumor efficacy ( Anwar et al, 2018 ; Sallam et al, 2020 ). Stehle et al previously reported the synthesis of the MTX–HSA conjugate by direct carbodiimide coupling of MTX to the lysine residue in albumin ( Stehle et al, 1997 ).…”

“…The latter have been employed as a strategy to enhance drug stability, solubility, and circulation time ( Tran and Tran, 2019 ). Moreover, they help protect the normal body cells against the cytotoxic effect of chemotherapeutics by controlling the drug to be released at specific sites and in the presence of specific enzymes ( Dolz-Pérez et al, 2020 ; Sallam et al, 2020 ). Additionally, Lf being a component of body innate immune system possesses merits compared to synthetic polymers that are employed for the synthesis of polymer–drug conjugates.…”

Potential Privilege of Maltodextrin-α-Tocopherol Nano-Micelles in Seizing Tacrolimus Renal Toxicity, Managing Rheumatoid Arthritis and Accelerating Bone Regeneration

“…Tailored MD-α-TOC bioconjugates were synthesized following a simple carbodiimide method. 12 , 26 Chemical entities and physicochemical properties of maltodextrin-α-tocopherol were investigated and confirmed by several techniques. 12 Noteworthy, synthesized biopolymers were obtained by utilizing two natural substrates whose merits were numerous owing to their biocompatibility, low immunogenicity, well-known structure and good tolerability within the human body.…”

Formulation‐based approaches for dermal delivery of vaccines and therapeutic nucleic acids: Recent advances and future perspectives

“… 61 HA has been widely implemented as a delivery agent of microscale particles for intranasal delivery of influenza vaccines. 62 It also acts as a transdermal nanocarrier of macromolecules, such as human growth hormone 63 as well as small molecules 64 and peptides.…”